• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
HGH

HEARTLAND GROUP HOLDINGS LIMITED - Charts / Financials

1.08% ! 93.5¢
Market Cap $881.2M  !
Financial Services Banks - Global
Add to My Watchlist

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits
refresh Created with Sketch. REFRESH
Day
Open 92.5¢   Day High 94.0¢   Day Low 92.0¢
Daily Volume 36081
Bids   Sellers
Number Price Volume   Number Price Volume
1 92.0¢ 10000   1 95.0¢ 2105

Data source: Refinitiv

Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
93.5¢ 		Change
0.010(1.08%) 		Mkt cap ! $881.2M
Open High Low Value Volume
92.5¢ 94.0¢ 92.0¢ $33.65K 36.08K

Buyers (Bids)

No. Vol. Price($)
1 10000 92.0¢
 

Sellers (Offers)

Price($) Vol. No.
95.0¢ 2105 1
View Market Depth
Last trade - 15.16pm 14/11/2025 (20 minute delay) ?

Top Stories

Week 46 Wrap: I feel like the Santa Rally isn't going to happen this year either. Also, Simandou is here

Well, what a week it’s been. The ASX200 is back down to the 8,640s as I write this (at 2.25pm AEDT) and that means 1Y returns for the index are down to +5%. Not that long ago, the XJO was looking at YTD returns of +10% when the US-Australia critical minerals deal was the flavour o...
NSXA Acquisition, Gold Volatility & Global Trends | The Market this Month, Ep 10 of 2025 Anna Serin reports from Perth as the CSE completes NSX acquisition, with Bruce Campbell analysing gold, the U.S. dollar, and Bitcoin trends.
PYC reports Phase II success in treating degenerative blindness condition PYC Therapeutics (ASX:PYC) has reported its investigational drug candidate, VP-001, has shown success in patients with Retinitis Pigmentosa type 11 (RP11) in Phase 1/2 clinical trials where improvements were reported by patients for up to 18 months after treatment. Listen to the HotCopper podcast...
Future Battery lauds 'step change' at Miriam after bumper Phase Two drilling results Future Battery Minerals has concluded phase two drilling at its Miriam Gold Project in WA, where the explorer unlocked a "step change."
Magnum Mining kicks off REE drilling at Azimuth Project in Brazil Magnum Mining (ASX:MGU) has kicked off drilling for rare earth elements (REEs) at its Azimuth Project in Brazil where the company’s now got auger rigs spinning as the geotech team kicks off early-stage surface drillworks. Listen to the HotCopper podcast for in-depth discussions an...
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.